| A. muciniphila | Akkermansia muciniphila |
| ABCA1 | ATP-binding cassette transporter A1 |
| ABCG2 | ATP-binding cassette super-family G member 2 |
| ACC | Acetyl-CoA carboxylase |
| Akt | Protein kinase B (also part of PI3K-Akt pathway) |
| AMPK | AMP-activated protein kinase |
| ApoA-I | Apolipoprotein A-I |
| ApoE | Apolipoprotein E |
| AS | Atherosclerosis |
| ASBT | Apical sodium-dependent bile acid transporter |
| ASCVD | Atherosclerotic cardiovascular disease |
| ATG16L1 | Autophagy related 16 like 1 |
| B. uniformis | Bacteroides uniformis |
| bai | Bile acid-inducible (operon) |
| BARs | Bile acid receptors |
| BAs | Bile acids |
| B-GOS | Bifidobacterial-galacto-oligosaccharides |
| BSH | Bile salt hydrolase |
| CA | Cholic acid |
| CAR | Constitutive androstane receptor |
| CD14 | Cluster of differentiation 14 |
| CD204 | Cluster of differentiation 204 |
| CD36 | Cluster of differentiation 36 |
| CDCA | Chenodeoxycholic acid |
| COX-2 | Cyclooxygenase-2 |
| COVID-19 | Coronavirus disease 2019 |
| CRC | Colorectal cancer |
| CVD | Cardiovascular disease |
| CYP27A1 | Cytochrome P450 family 27 subfamily A member 1 |
| CYP7A1 | Cytochrome P450 family 7 subfamily A member 1 |
| CYP7B1 | Cytochrome P450 family 7 subfamily B member 1 |
| DCA | Deoxycholic acid |
| DCs | Dendritic cells |
| DIP | Dictyophora indusiata polysaccharide |
| DMB | 3,3-dimethyl-1-butanol |
| E. coli | Escherichia coli |
| EDH | Endothelium-derived hyperpolarization |
| EGFR | Epidermal growth factor receptor |
| ENS | Enteric nervous system |
| eNOS | Endothelial nitric oxide synthase |
| ERK1/2 | Extracellular signal-regulated kinase 1/2 |
| F. prausnitzii | Faecalibacterium prausnitzii |
| F/B | Firmicutes/Bacteroidetes (ratio) |
| FASN | Fatty acid synthase |
| FFAR2 | Free fatty acid receptor 2 |
| FFAR3 | Free fatty acid receptor 3 |
| FMC | Fluoromethylcholine |
| FMO3 | Flavin monooxygenase 3 |
| FMT | Fecal microbiota transplantation |
| FOXP3 | Forkhead box P3 |
| FXR | Farnesoid X receptor |
| G6Pase | Glucose-6-phosphatase |
| GABA | Gamma-aminobutyric acid |
| GF | Germ-free |
| GLP-1 | Glucagon-like peptide 1 |
| GPCR | G-protein coupled receptor |
| GPR41 | G-protein coupled receptor 41 |
| H. pylori | Helicobacter pylori |
| HDAC | Histone deacetylase |
| HDACs | Histone deacetylases |
| HDL | High-density lipoprotein |
| HFD | High-fat diet |
| HGM | Human gut microbiome |
| HMG-CoA | 3-hydroxy-3-methylglutaryl-coenzyme A |
| HSDH | Hydroxysteroid dehydrogenase |
| I3C | Indole-3-carbinol |
| IBD | Inflammatory bowel disease |
| IBS | Irritable bowel syndrome |
| ICAM-1 | Intercellular adhesion molecule 1 |
| IEC | Intestinal epithelial cell |
| IECs | Intestinal epithelial cells |
| IFIT1 | Interferon-induced protein with tetratricopeptide repeats 1 |
| IgA | Immunoglobulin A |
| IgG | Immunoglobulin G |
| IL-1 | Interleukin-1 |
| IL-1β | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| IMC | Iodomethylcholine |
| isoalloLCA | Isoallolithocholic acid |
| JNK | c-Jun N-terminal kinase |
| LAL | Limulus Amoebocyte Lysate |
| LBP | Lipopolysaccharide-binding protein |
| LCA | Lithocholic acid |
| LDL | Low-density lipoprotein |
| LDLr | Low-density lipoprotein receptor |
| LL-37 | Cathelicidin antimicrobial peptide |
| LOX-1 | Lectin-like oxidized low-density lipoprotein receptor-1 |
| LPS | Lipopolysaccharides |
| M1 | Macrophage type 1 |
| M2 | Macrophage type 2 |
| MAPK | Mitogen-activated protein kinase |
| MCP-1 | Monocyte chemoattractant protein 1 |
| MCT1 | Monocarboxylate transporter 1 |
| MCT4 | Monocarboxylate transporter 4 |
| MD-2 | Myeloid differentiation factor 2 |
| MDA | Malondialdehyde |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| mtROS | Mitochondrial reactive oxygen species |
| MUC2 | Mucin 2 |
| MyD88 | Myeloid differentiation primary response 88 |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NEU1 | Neuraminidase 1 |
| NET | Neutrophil extracellular trap |
| NF-κB | Nuclear factor kappa B |
| NK | Natural killer |
| NKT | Natural killer T |
| NLRP3 | NLR family pyrin domain containing 3 |
| NO | Nitric oxide |
| NOD1 | Nucleotide-binding oligomerization domain 1 |
| NOD1/2 | Nucleotide-binding oligomerization domain 1/2 |
| NOD2 | Nucleotide-binding oligomerization domain 2 |
| NPC1L1 | Niemann-Pick C1-like 1 |
| NR4A1 | Nuclear receptor subfamily 4 group A member 1 |
| NR4A2 | Nuclear receptor subfamily 4 group A member 2 |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| Olfr78 | Olfactory receptor 78 |
| OSTα/OSTβ | Organic solute transporter alpha/beta |
| oxLDL | Oxidized low-density lipoprotein |
| P. gingivalis | Porphyromonas gingivalis |
| PAF | Platelet-activating factor |
| PAMPs | Pathogen-associated molecular patterns |
| PD-L1 | Programmed death-ligand 1 |
| PEPCK | Phosphoenolpyruvate carboxykina |
| Biomarker | A measurable biological parameter that reflects physiological or pathological processes, or response to a therapeutic intervention. |
| Dysbiosis | An imbalance in gut microbiota composition, diversity, or function, associated with disease states. |
| Eubiosis | A balanced microbial community structure compatible with health and homeostasis. |
| Fecal microbiota transplantation (FMT) | Therapeutic transfer of stool from a healthy donor to a patient in order to restore microbiota balance. |
| Gut microbiota | The community of microorganisms (bacteria, viruses, fungi, archaea) inhabiting the human gastrointestinal tract. |
| Microbiota-derived metabolites | Small molecules produced by microbial metabolism (e.g., TMAO, SCFAs, bile acids) that can affect host physiology. |
| SCFAs (Short-chain fatty acids) | Fermentation products of dietary fibers by gut microbiota, including acetate, propionate, and butyrate. |
| TMAO (Trimethylamine N-oxide) | A gut microbiota-derived metabolite from dietary choline and carnitine, associated with cardiovascular risk. |